Ben Jackson
@btjackson.bsky.social
Cell biologist, metabolism enthusiast, incoming anesthesiologist at UCSF | Tri-I MD-PhD in NYC
I'm excited to share our latest story from the
@lydiafinley.bsky.social lab, where we show that it's not just whether cells take up nutrients that matters, but how and where those metabolites are used. Out now in @naturemetabolism.bsky.social: rdcu.be/ejFTs 1/
@lydiafinley.bsky.social lab, where we show that it's not just whether cells take up nutrients that matters, but how and where those metabolites are used. Out now in @naturemetabolism.bsky.social: rdcu.be/ejFTs 1/
Intracellular metabolic gradients dictate dependence on exogenous pyruvate
Nature Metabolism - Jackson et al. provide insight into how metabolic adaptations that accompany cell state transitions drive reliance on exogenous nutrient availability, focusing on pyruvate as a...
rdcu.be
April 28, 2025 at 2:28 PM
I'm excited to share our latest story from the
@lydiafinley.bsky.social lab, where we show that it's not just whether cells take up nutrients that matters, but how and where those metabolites are used. Out now in @naturemetabolism.bsky.social: rdcu.be/ejFTs 1/
@lydiafinley.bsky.social lab, where we show that it's not just whether cells take up nutrients that matters, but how and where those metabolites are used. Out now in @naturemetabolism.bsky.social: rdcu.be/ejFTs 1/
Reposted by Ben Jackson
Thrilled that my thesis work in @lydiafinley.bsky.social's lab is out in the world! We found that methotrexate targets a specific metabolic vulnerability in a particularly aggressive form of pediatric rhabdomyosarcoma. Thank you to everyone who contributed to this project over the years!
PAX3-FOXO1 drives targetable cell state-dependent metabolic vulnerabilities in rhabdomyosarcoma https://www.biorxiv.org/content/10.1101/2025.01.15.633227v1
January 20, 2025 at 4:45 PM
Thrilled that my thesis work in @lydiafinley.bsky.social's lab is out in the world! We found that methotrexate targets a specific metabolic vulnerability in a particularly aggressive form of pediatric rhabdomyosarcoma. Thank you to everyone who contributed to this project over the years!
Reposted by Ben Jackson
Our latest preprint identifies (targetable!) metabolic programs intrinsic to different cancer cell states in rhabdomyosarcoma, out just in time for @katrinaparas.bsky.social's thesis defense tomorrow!
PAX3-FOXO1 drives targetable cell state-dependent metabolic vulnerabilities in rhabdomyosarcoma https://www.biorxiv.org/content/10.1101/2025.01.15.633227v1
January 20, 2025 at 4:20 PM
Our latest preprint identifies (targetable!) metabolic programs intrinsic to different cancer cell states in rhabdomyosarcoma, out just in time for @katrinaparas.bsky.social's thesis defense tomorrow!
Thrilled that my first post here is this absolutely monumental work by @katrinaparas.bsky.social and the @lydiafinley.bsky.social lab. It’s been so much fun to watch this story develop; read it if you have any interest in cell state, pediatric cancer, or of course metabolism!
PAX3-FOXO1 drives targetable cell state-dependent metabolic vulnerabilities in rhabdomyosarcoma https://www.biorxiv.org/content/10.1101/2025.01.15.633227v1
January 20, 2025 at 4:31 PM
Thrilled that my first post here is this absolutely monumental work by @katrinaparas.bsky.social and the @lydiafinley.bsky.social lab. It’s been so much fun to watch this story develop; read it if you have any interest in cell state, pediatric cancer, or of course metabolism!